Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BTAI

BioXcel Therapeutics

$3.38

-0.49 (-12.66%)

08:37
01/03/19
01/03
08:37
01/03/19
08:37
Hot Stocks
BioXcel Therapeutics dexmedetomidine trial meets primary endpoint »

BioXcel Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

WATT

Energous

$4.57

-0.17 (-3.59%)

, BTAI

BioXcel Therapeutics

$2.44

-0.33 (-11.91%)

09:04
12/27/18
12/27
09:04
12/27/18
09:04
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Energous (WATT),…

WATT

Energous

$4.57

-0.17 (-3.59%)

BTAI

BioXcel Therapeutics

$2.44

-0.33 (-11.91%)

AXSM

Axsome Therapeutics

$2.06

-0.1 (-4.63%)

JD

JD.com

$21.11

1.36 (6.89%)

JPM

JPMorgan

$95.91

3.92 (4.26%)

JKS

JinkoSolar

$10.19

0.655 (6.87%)

V

Visa

$130.19

9.08 (7.50%)

VZ

Verizon

$54.45

1.46 (2.76%)

DIS

Disney

$105.84

5.64 (5.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

  • 07

    Jan

  • 09

    Jan

  • 15

    Jan

  • 16

    Jan

  • 29

    Jan

  • 05

    Feb

  • 26

    Feb

  • 03

    Mar

BTAI

BioXcel Therapeutics

$2.44

-0.33 (-11.91%)

08:22
12/27/18
12/27
08:22
12/27/18
08:22
Hot Stocks
BioXcel Therapeutics receives fast track designation for BXCL501 from FDA »

BioXcel Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

Over a month ago
BTAI

BioXcel Therapeutics

$3.42

-0.29 (-7.82%)

05:48
12/19/18
12/19
05:48
12/19/18
05:48
Hot Stocks
BioXcel doses first subjects in Phase 1 pharmacokinetic study of BXCL501 »

BioXcel Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTAI

BioXcel Therapeutics

$4.55

-0.12 (-2.57%)

05:34
12/12/18
12/12
05:34
12/12/18
05:34
Hot Stocks
BioXcel Therapeutics announces FDA acceptance of IND for BXCL501 »

BioXcel Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BTAI

BioXcel Therapeutics

$5.02

-0.09 (-1.76%)

07:10
12/05/18
12/05
07:10
12/05/18
07:10
Recommendations
BioXcel Therapeutics analyst commentary at H.C. Wainwright »

BioXcel Therapeutics data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BTAI

BioXcel Therapeutics

$5.93

0.3 (5.33%)

07:10
11/09/18
11/09
07:10
11/09/18
07:10
Earnings
BioXcel Therapeutics reports Q3 EPS (31c), consensus (29c) »

As of September 30, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

BTAI

BioXcel Therapeutics

$5.52

-0.04 (-0.72%)

05:37
11/05/18
11/05
05:37
11/05/18
05:37
Hot Stocks
BioXcel Therapeutics announces FDA acceptance of IND for BXCL701 »

BioXcel Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

BTAI

BioXcel Therapeutics

$5.23

-0.05 (-0.95%)

04:55
11/01/18
11/01
04:55
11/01/18
04:55
Conference/Events
BioXcel Therapeutics management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

BTAI

BioXcel Therapeutics

$5.01

-0.05 (-0.99%)

11:20
10/30/18
10/30
11:20
10/30/18
11:20
Conference/Events
BioXcel Therapeutics management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.